2015
Acetyl-L-Carnitine in the Treatment of Peripheral Neuropathic Pain: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Abstract: ObjectiveAcetyl-L-carnitine (ALC), a constructive molecule in fatty acid metabolism, is an agent potentially effective for treating peripheral neuropathic pain (PNP). Its effect, however, remains uncertain. We aimed to access the efficacy and safety of ALC for the treatment of patients with PNP.MethodsWe searched MEDLINE (1996–2014), EMBase (1974–2014), and CENTRAL (May 2014) up to June 27, 2014 for randomized controlled trials (RCTs) comparing ALC with placebo or other active medications in diabetic and non-d…
Search citation statements
Paper Sections
Select...
35
9
7
2
Citation Types
2
21
1
0
Year Published
2015
2026
Publication Types
Select...
38
8
1
Relationship
1
46
Authors
Journals
Cited by 43 publications
(24 citation statements)
References 30 publications
2
21
1
0
“…Though our patients did not present with extremely painful neuropathy (mean pain score about 19 out of 38) [ 53 ], the pain level in the present study significantly decreased by 7%. Similar effects could be shown in our previous study [ 51 ] and other studies [ 3 , 33 , 63 , 75 ]. These findings once again confirm the analgesic action of B12 [ 63 , 73 ], possibly mediated by an increase of the availability and effectiveness of noradrenaline and 5-hydroxytryptamine [ 76 ] in the descending inhibitory pain modulation system (endogenous opioid system).…”
Section: Discussionsupporting
confidence: 92%
“…Though our patients did not present with extremely painful neuropathy (mean pain score about 19 out of 38) [ 53 ], the pain level in the present study significantly decreased by 7%. Similar effects could be shown in our previous study [ 51 ] and other studies [ 3 , 33 , 63 , 75 ]. These findings once again confirm the analgesic action of B12 [ 63 , 73 ], possibly mediated by an increase of the availability and effectiveness of noradrenaline and 5-hydroxytryptamine [ 76 ] in the descending inhibitory pain modulation system (endogenous opioid system).…”
Section: Discussionsupporting
confidence: 92%
“……”
Section: Resultssupporting
confidence: 84%
“…To be noted, ALC was compared with MC in a recent trial among patients with chemotherapy-induced peripheral neuropathy, and ALC was found less efficacious than MC in alleviating neuropathic symptoms 27 . This difference from the present study might be explained by a higher potency of ALC for neuropathy induced by diabetes than other etiologies, as supported by a recent meta-analysis 10 .…”
Section: Discussioncontrasting
confidence: 57%
